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Leishmania alternates between two morphologically different stages, promastigotes and amastigotes.
While the majority of reports focused on how the promastigote form can alter macrophage (M) signaling
and function, fewer reports investigated signaling alterations mediated by amastigotes, and there is a lack
of comparative studies. In this study, we performed a comparison between the ability of both forms of the
parasite to alter M signaling and functions. Here, we show that both promastigotes and amastigotes were
able to rapidly activate host protein tyrosine phosphatases (PTPs), importantly the Src homology 2
domain-containing PTP (SHP-1). However, we found that PTP-1B is specifically activated by promastigote
but not amastigote infection and that lmcpb/ promastigotes were no longer able to activate PTP-1B. We
also show a similarity in the way promastigotes and amastigotes inactivate the transcription factors (TFs)
STAT-1 and AP-1, but we show differences in the modulation of NF-B, with promastigotes cleaving the
p65 subunit, generating a smaller p35 subunit, and amastigotes fully degrading the p65 subunit with no
p35 production. Importantly, we show that the cysteine proteinase LmCPb plays a key role in the
alteration of NF-B, STAT-1, and AP-1 by promastigote and amastigote infections, ultimately leading to
the inability of these TFs to translocate to the nucleus in response to gamma interferon (IFN-) stimu-
lation and thus contributing to the ability of both parasite forms to effectively block IFN--mediated nitric
oxide (NO) production in Ms.
Leishmania parasites are prevalent in more than 80 coun-
tries in the world. It is estimated that there are 12 million cases
of leishmaniasis worldwide, with 2 million new cases emerging
every year (8). The most common manifestations of the disease
are as follows: (i) visceral leishmaniasis caused by Leishmania
donovani and Leishmania chagasi and responsible for the ma-
jority of mortality cases, (ii) cutaneous leishmaniasis caused
principally by Leishmania major and Leishmania mexicana and
is the most common manifestation of the disease, and (iii) the
disfiguring mucocutaneous leishmaniasis caused by Leishma-
nia braziliensis (23).
Leishmania is a dimorphic protozoan alternating between
the promastigote and amastigote stages. Promastigotes have an
elongated shape with long flagella and live inside the sand fly
vector. Once promastigotes are deposited into mammalian
skin while the sand fly is having a blood meal, they are phago-
cytosed by cells of the monocyte/macrophage (M) lineage
and rapidly transform into round amastigotes that are smaller
than the promastigotes and lack external flagella (23). In ad-
dition to being morphologically different, the two life stages of
the parasite have different surface molecule compositions.
While infectious metacyclic promastigotes have a thick glyco-
calyx, this cover is almost completely absent in amastigotes
(33). The glycocalyx is made of glycoproteins and other
glycosylated species anchored to the surface membrane by a
glycosylphosphatidylinositol (GPI) linkage (10). The pro-
mastigote surface is predominantly covered by lipophospho-
glycan (LPG), a GPI-anchored molecule made of repeating
units of a disaccharide and a phosphate. Buried in a sea of
LPG, promastigotes have another important GPI-anchored
molecule, the surface protease gp63. Interestingly, amasti-
gotes have been shown to produce very little LPG compared
to promastigotes (21) and have less gp63 (38) that, in the
case of L. mexicana, has been shown to lack a GPI anchor
and to be confined to the flagellar pocket (22).
Although LPG and, to a lesser extent, gp63 are the most
studied virulence factors in Leishmania, other important
virulence factors found in several Leishmania species in-
clude clan CA, family C1 cysteine proteinases (CPs) (26). L.
mexicana has been shown to have cathepsin L-like CP genes
(lmcpb) that are present in multiple copies and occur in a
tandem array (39) and two single-copy CP genes, the ca-
thepsin L-like gene (lmcpa) and the other cathepsin B-like
gene (lmcpc). Unlike LPG and gp63, which are plentiful in
promastigotes and are downregulated in amastigotes,
LmCPb (L. mexicana cysteine proteinase b) is expressed at
low levels in metacyclic promastigotes and is strongly up-
regulated in amastigotes (39), indicating that the protein
may play a crucial role in the intracellular survival of the
parasite.
Given that promastigotes have to avoid M microbicidal
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action in order to establish themselves in the host and that
amastigotes have to suppress M killing abilities when they try
to invade new Ms in the course of a persistent Leishmania
infection, it is not surprising that both forms of the parasite can
alter key M signaling pathways (31). Indeed, several studies
have previously shown that promastigotes (1, 12, 35, 36) and
amastigotes (24, 36, 41), or molecules derived from them, are
able to block nitric oxide (NO) production by host Ms in
response to activating stimuli, such as gamma interferon
(IFN-) or bacterial lipopolysaccharide (LPS). The promasti-
gote surface contains several glycoconjugates allowing interac-
tion with Ms and internalization via several types of recep-
tors, such as complement receptors 1, 3, and 4 (18, 40), the
mannose fucose receptor (3), the C-reactive protein receptor
(9), and the fibronectin receptor (6). On the other hand, amas-
tigotes lack many of those glycoconjugates and seem to inter-
act with Ms mainly through glycosylinositol phospholipids
(GIPLs) and to be phagocytosed via the Fc receptor follow-
ing opsonization by antibodies or via complement receptors.
Although redundancies might exist in the way promastigotes
and amastigotes interact with Ms and modulate their signal-
ing in order to block their killing functions, the differences
between both forms, whether at the gene expression, meta-
bolic, or surface molecule level suggest to us that some differ-
ences ought to exist in the way those two forms can modulate
M signaling to their own favor. This work is an effort to
compare the similarities and differences between promasti-
gotes and amastigotes of L. mexicana in terms of their ability to
alter key signaling molecules, namely, protein tyrosine phos-
phatases (PTPs) and the transcription factors (TFs) nuclear
factor kappa B (NF-B), signal transducer and activator of
transcription 1alpha (STAT-1), and activating protein 1 (AP-
1), known to play a pivotal role in NO production (19, 42) as
well as other M functions detrimental to the survival of the
Leishmania parasite (31). In addition, given the established
role of LmCPb as a virulence factor and an immunomodulator
(2, 27), this work explores the role of this proteinase in the
Leishmania-induced alterations of signaling molecules that we
observed.
MATERIALS AND METHODS
Cell culture and reagents. The immortalized B10R bone marrow-derived Ms
(BMDMs) were derived from B10A.Bcgr mice (37). The immortalized me-3
(SHP-1/) and LM-1 (wild-type [WT]) BMDMs were generated from moth-
eaten mice (Ptpn6me/me; C3HeBFeJ me/me) and their respective wild-type litter-
mates (C3HeBFeJ me/) as previously described (14). Recombinant murine
IFN- was purchased from Cedarlane, NC. Antibodies used to immunoprecipi-
tate SHP-1 and PTP-1B were purchased from Upstate, NY.
In vitro infection. Promastigotes of L. mexicana (MNYC/BZ/62/M379), and L.
mexicana deficient for LmCPb generated by targeted gene deletion as previously
described (27) were kept in SDM medium (10% fetal bovine serum [FBS]) (32),
and stationary-phase parasites were used to infect cells in a parasite-to-M ratio
ranging from 5:1 to 20:1. Axenic amastigotes of WT and lmcpb/ L. mexicana
were transformed from promastigote cultures, kept in MAA medium (medium
for axenically grown amastigotes, pH 5.6, 20% FBS) (27), and incubated at a
temperature of 32°C. When parasites were used for infections, noninternalized
ones were removed by washing the plates with phosphate-buffered saline (PBS),
after which Ms were collected for subsequent experiments.
Western blot analysis. Western blotting was performed as previously described
(32). Proteins were detected using antibodies directed against gp63 (provided by
Robert McMaster, University of British Columbia, Canada), LACK (provided by
Eric Prina, Institut Pasteur, France), A2 (provided by Greg Matlashewski,
McGill University, Canada), SHP-1 (Chemicon, CA), and PTP-1B (Upstate).
Proteins were detected using a horseradish peroxidase (HRP)-conjugated anti-
rabbit or anti-mouse antibody (Amersham, QC, Canada) and visualized using
ECL Western blotting detection system (Amersham).
NO assay. NO production was evaluated by measuring the accumulation of
nitrite in the culture medium by the Griess reaction, as previously described (13).
pNPP phosphatase assay. Ms were collected, lysed in PTP lysis buffer (50
mM Tris [pH 7.0], 0.1 mM EDTA, 0.1 mM EGTA, 0.1% -mercaptoethanol, 1%
Igepal, 25 g/ml aprotinin, and 25 g/ml leupeptin), and kept on ice for 45 min.
Lysates were cleared by centrifugation, and protein content was determined by
using the Bradford reagent. For experiments measuring phosphatase activity in
total cell lysates, the lysates (30 g) were incubated in a phosphatase reaction
mix (50 mM HEPES [pH 7.5], 0.1% -mercaptoethanol, 10 mM p-nitrophe-
nylphosphate [pNPP]) for 30 min at 37°C, and the optical density (OD) at 405 nm
was read. For experiments measuring phosphatase activity in immunoprecipi-
tates (IPs), cell lysates were subjected to immunoprecipitation using protein A/G
agarose beads (Santa Cruz, CA) and 3 g of the SHP-1, PTP-1B, or the anti-rat
(Sigma-Aldrich, ON, Canada) antibody for nonspecific binding. The beads were
spun down and washed three times with the PTP lysis buffer and then incubated
with the phosphatase reaction mix for 4 to 6 h at 37°C, and the OD at 405 nm was
read.
In-gel PTP assay. Cell lysates (30 g) were obtained using the PTP lysis buffer
previously described. Samples were loaded on a gel containing a -32P-labeled
poly(Glu4Tyr) peptide (Sigma-Aldrich), and PTP bands were observed by in-gel
PTP assay as previously described (20).
EMSA. Nuclear extracts were prepared by a standard protocol, and elec-
trophoretic mobility shift assays (EMSAs) were performed as previously
described (17). Briefly, nuclear extracts were incubated with binding buffer
(11) containing 1.0 ng of [-32P]dATP radiolabeled double-stranded DNA
oligonucleotide for 20 min at room temperature. The DNA binding consensus
sequences used for transcription factors are as follows: 5	-AGTTGAGGGG
ACTTTCCCAGGC-3	 for NF-B, 5	-AAGTACTTTCAGTTTCATATTACT
CTA-3	 for STAT-1 (gamma interferon activation site [GAS]/interferon-
stimulated response element [ISRE] consensus sequence), and 5	-AGCTCG
CGTGACTCAGCTG-3	 for AP-1. Sp1 consensus oligonucleotide was used
as a nonspecific control (5	-ATTCGATCGGGGCGGGGCGAGC-3	) (all
DNA oligonucleotides were purchased from Santa Cruz). DNA-protein com-
plexes were resolved by electrophoresis in native 4% (wt/vol) polyacrylamide
gels. The gels were then dried and autoradiographed.
RESULTS
Promastigotes and amastigotes of L. mexicana efficiently
block IFN--mediated NO production in Ms. To investigate
whether both promastigotes and amastigotes were able to in-
hibit IFN--mediated NO production in our experimental sys-
tem, NO levels were measured in B10R Ms infected with one
of the two forms, followed by IFN- stimulation. Results
showed that both promastigotes and axenic amastigotes of L.
mexicana were able to significantly block IFN--mediated NO
production in Ms (Fig. 1A). Successful differentiation of L.
mexicana promastigotes to amastigotes was confirmed by sev-
eral methods: morphological changes seen by phase-contrast
microscopy (data not shown), the remarkably decreased level
of production of gp63 in amastigotes compared to promasti-
gotes (Fig. 1B, top panel), and the detection of the amastigote-
specific A2 protein in amastigote but not promastigote lysates
(Fig. 1B, middle panel). The LACK D protein was used as a
loading control (Fig. 1B, bottom panel).
Promastigotes and amastigotes of L. mexicana activate PTPs
in Ms. We have previously reported that Leishmania dono-
vani promastigotes can rapidly increase total PTP activity in
Ms to alter their signaling pathways (5). Here, we performed
pNPP phosphatase assays to compare the ability of promasti-
gotes and amastigotes of L. mexicana to rapidly activate PTPs
in Ms. Results indicated that both promastigotes and amas-
tigotes were able to rapidly increase total PTP activity in in-
fected Ms, reaching a peak activation value at 6 h postinfec-
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tion and decreasing thereafter (Fig. 2A). To obtain a better
understanding of the specific PTPs involved in this activation,
we performed in-gel PTP assays screening for different M
PTPs and monitoring their alterations with promastigote or
amastigote infections over a 24-h infection period. In-gel PTP
assays showed that both promastigotes and amastigotes were
able to rapidly activate the Src homology 2 domain-containing
protein tyrosine phosphatase (SHP-1) seen by the appearance
of a cleavage product associated with the activation of SHP-1
(Fig. 2B, top two arrows). Interestingly, while promastigote
infection clearly activated PTP-1B, resulting in a cleavage frag-
ment, the generation of this active cleaved form by amastigotes
was minimal (Fig. 2B, bottom two arrows).
L. mexicana’s cysteine proteinase LmCPb plays a role in
PTP-1B but not SHP-1 activation in Ms. One important
virulence factor expressed in metacyclic promastigotes and in
amastigotes of L. mexicana is the cysteine proteinase LmCPb.
To evaluate a possible role for LmCPb in the activation of
SHP-1 and PTP-1B, we performed in-gel PTP assays, Western
blotting, and pNPP phosphatase assays on lysates and immu-
noprecipitates (IPs) of Ms infected with WT or lmcpb/
promastigotes and amastigotes and evaluated the effects of
these parasites on SHP-1 and PTP-1B cleavage and activation.
Although there was some reduced cleavage of SHP-1’s top
band in Ms infected with lmcpb/ promastigotes and amas-
tigotes (Fig. 3A, top arrow, and Fig. 3B, top panel), its lower
cleavage band was still prominent (Fig. 3A, second arrow from
the top, and Fig. 3B, top panel), and SHP-1’s IP from Ms
infected by lmcpb/ parasites exhibited elevated phosphatase
activity, similar to that caused by WT parasites (Fig. 3C, top
graph), suggesting that LmCPb is not required in the Leish-
mania-induced SHP-1 activation.
Conversely, infection with lmcpb/ parasites did not lead to
the cleavage of the top PTP-1B band seen with WT promas-
tigotes (Fig. 3A, third arrow from the top, and Fig. 3B, bottom
panel), resulting in a strong reduction in the cleavage band that
we observe in WT promastigote infection (Fig. 3A, bottom
arrow, and Fig. 3B, bottom panel). This decrease in PTP-1B
cleavage was associated with the inability of lmcpb/ parasites
to cause PTP-1B activation compared to WT promastigote
infection (Fig. 3C, bottom graph). This set of data suggests that
LmCPb seems to play a role in the activation of PTP-1B in L.
mexicana promastigotes.
Ability of L. mexicana promastigotes and amastigotes to
alter M TFs. Because TFs NF-B, STAT-1, and AP-1
are strong modulators of M signaling, we decided to study
the ability of promastigotes and amastigotes of L. mexicana
to alter key M TFs, namely, NF-B, STAT-1, and AP-1.
We also evaluated the lowest parasite-to-cell ratio required
to cause these alterations. EMSAs revealed that both pro-
mastigotes and amastigotes were able to cause the disap-
pearance of the p65-containing subunit of NF-B but with
different results. Promastigotes cleaved p65 into a p35-con-
taining subunit, while amastigotes caused a total degrada-
FIG. 1. Inhibition of IFN--mediated NO production by L. mexi-
cana promastigotes (Pro) and amastigotes (Ama). (A) NO assay of
B10R Ms left untreated () (bar 1), stimulated with IFN- (100
U/ml) for 24 h () (bar 2), infected with Leishmania (overnight [O/N],
20:1 ratio) () (bars 3 and 5), or infected with Leishmania (O/N, 20:1
ratio) and then stimulated with IFN- (100 U/ml) for 24 h (bars 4 and
6). The values are means plus standard errors of the means (SEMs)
(error bars). Values that were significantly different (P 
 0.05, analysis
of variance [ANOVA] test) are indicated by an asterisk. (B) Western
blot analysis of L. mexicana promastigote and amastigote cell lysates
(40 g). The membrane was cut and blotted for gp63 (top panel) and
A2 (middle panel). The membrane was then stripped and reblotted for
LACK D (bottom panel) to demonstrate equal loading. All results are
representative of at least three independent experiments. w.b., West-
ern blotted.
FIG. 2. Activation of host PTPs by L. mexicana promastigotes and amastigotes. (A) B10R Ms were infected with L. mexicana promastigotes
or amastigotes for the specified time course (0 to 24 h, 20:1 ratio), and total PTP activity of M lysates (20 g) was measured using the pNPP
phosphatase assay. (B) Cell lysates (30 g) of Ms infected with promastigotes or amastigotes of L. mexicana for the specified time course (0 to
24 h, 20:1 ratio) subjected to an in-gel PTP assay. The rightmost two lanes contain lysates (30 g) from WT and SHP-1/ Ms to confirm the
band corresponding to SHP-1. All results are representative of at least three independent experiments.
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tion of this subunit with no observable production of the p35
subunit (Fig. 4A). Interestingly, both promastigotes and
amastigotes inhibited STAT-1 and AP-1 activity, but gen-
erally, a stronger effect was seen with amastigote infection
(Fig. 4B and C). Additionally, a parasite-to-cell ratio of 5:1
was sufficient to observe the previously mentioned alter-
ations (Fig. 4A, B, and C) and was thus selected for the rest
of the EMSA experiments conducted.
FIG. 3. Role of LmCPb in PTP-1B activation. (A) B10R Ms were infected with L. mexicana promastigotes and amastigotes of WT and
lmcpb/ parasites for the specified time course (0 to 6 h, 20:1 ratio), and cell lysates (30 g) were subjected to an in-gel PTP assay. The rightmost
two lanes contain lysates (30 g) from WT and SHP-1/ Ms to confirm the band corresponding to SHP-1. (B) Samples in panel A were run
on gels by SDS-PAGE and blotted for SHP-1 (top panel) and PTP-1B (bottom panel). w.b., Western blotted. (C) B10R Ms were infected with
L. mexicana promastigotes (P) and amastigotes (A) of WT and lmcpb/ parasites (3 h, 20:1 ratio) followed by lysis and immunoprecipitation of
SHP-1 or PTP-1B. The SHP-1 and PTP-1B IPs were subjected to a pNPP phosphatase assay (top and bottom graphs, respectively). The values are
means plus standard errors of the means (SEMs) (error bars). Values that were significantly different (P 
 0.05, ANOVA test) are indicated by
an asterisk. Rabbit anti-rat IgG was used as a negative control for the IPs. All results are representative of at least three independent experiments.
FIG. 4. Modulation of M TFs by L. mexicana promastigotes and amastigotes. B10R Ms were infected with L. mexicana promastigotes and
amastigotes at the specified parasite-to-cell ratios (3-h infection). (A to C) Nuclear proteins were extracted and subjected to EMSA to evaluate
DNA-binding activity of NF-B (A), STAT-1 (B), and AP-1 (C). S, specific competition (100-fold excess of specific nonradioactive oligonucle-
otide); NS, nonspecific competition (100-fold excess of nonspecific, nonradioactive Sp-1 oligonucleotide).
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LmCPb plays a crucial role in the ability of promastigotes
and amastigotes of L. mexicana to modulate NF-B, STAT-1,
and AP-1. To study the role of LmCPb in the modulation of the
different transcription factors, we performed EMSAs to eval-
uate the ability of lmcpb/ parasites to alter NF-B, STAT-
1, and AP-1. Results revealed that both promastigotes and
amastigotes of lmcpb/ parasites were not able to alter the
p65 subunit of NF-B (Fig. 5A) or to inhibit STAT-1 (Fig.
5B) and AP-1 (Fig. 5C) activity. The previously mentioned TFs
of Ms infected with lmcpb/ parasites remained intact and
similar to that of uninfected Ms, suggesting a crucial role for
LmCPb in the cleavage/degradation of NF-B and in the
blockage of STAT-1 and AP-1 activity in host Ms.
lmcpb-rescued parasites alter M signaling in a similar
manner to WT parasites. To rule out the possibility that the
protection of transcription factor alterations that we observe
when Ms are infected with lmcpb/ parasites is due to the
attenuation of those parasites as they are multiply passaged in
the knocking-out process, we investigated whether lmcpb add-
back parasites were also able to inhibit NF-B the way WT
parasites did. Results showed that indeed this was the case
(Fig. 6), suggesting that the lack of effect observed in lmcpb/
parasite-infected Ms is indeed due to the absence of this
protease and not an effect of parasite attenuation.
Unlike infection by WT parasites, TFs of Ms infected with
lmcpb/ parasites retain their ability to be activated by
IFN-. To evaluate whether the alteration of NF-B, STAT-
1, and AP-1 by WT promastigotes and amastigotes interferes
with the ability of those TFs to translocate to the nucleus and
to evaluate the role of LmCPb in this context, we performed
EMSAs. Results indicated that infection with WT promasti-
gotes and amastigotes of L. mexicana rendered p65-containing
subunits of NF-B, STAT-1, and AP-1 unresponsive to IFN-
stimulation (Fig. 7A, B, and C, respectively). Interestingly,
when Ms were infected with lmcpb/ parasites (Fig. 7A, B,
and C), these TFs were able to translocate to the nucleus and
FIG. 5. Role of LmCPb in the modulation of M TFs. B10R Ms infected for the specified time course (0.5 to 3 h) with WT or lmcpb/
promastigotes and amastigotes of L. mexicana in a 5:1 parasite-to-cell ratio. Nuclear proteins were extracted and subjected to EMSA to evaluate
DNA-binding activity of NF-B (A), STAT-1 (B), and AP-1 (C). S, specific competition (100-fold excess of specific nonradioactive oligonucleo-
tide); NS, nonspecific competition (100-fold excess of nonspecific, nonradioactive Sp-1 oligonucleotide).
FIG. 6. Effect of lmcpb-rescued parasites on M NF-B. B10R
Ms were infected for 1 h with L. mexicana amastigotes of WT,
lmcpb/, or lmcpb-rescued parasites. Nuclear proteins were extracted
and subjected to EMSA to evaluate DNA-binding activity of NF-B.
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bind their consensus sequences in a manner similar to that of
the IFN--only positive control.
Promastigotes and amastigotes of WT L. mexicana but not
lmcpb/ parasites are able to inhibit M NO production in
response to IFN- stimulation. To evaluate the impact of
LmCPb on M function, we performed NO assays to test
whether lmcpb/ parasites are able to block IFN--mediated
NO production by Ms in a fashion similar to that observed by
WT parasites. Results showed that while WT promastigotes
and amastigotes successfully inhibited IFN--mediated NO
production as illustrated in Fig. 1A, lmcpb/ parasites were
not able to do so. The levels of NO produced in response to
lmcpb/ parasites were comparable to those produced by
uninfected cells stimulated with IFN- (Fig. 8).
DISCUSSION
NO production by Ms plays a key role in the resolution of
Leishmania infections. Indeed, there are several publications
reporting the ability of promastigotes, amastigotes, or various
parasite molecules, such as lipophosphoglycan (LPG) (35) and
glycosylinositol phospholipids (GIPLs) (36), to inhibit M NO
production in response to activating stimuli. Of utmost inter-
est, none of those previous studies compared the ability of both
forms of the parasite to inhibit M NO production and the
negative regulatory mechanisms they employ to cause this in-
hibition.
We have previously reported the ability of Leishmania pro-
mastigotes to rapidly activate host PTPs (5). Furthermore, we
and others have shown that host SHP-1 is one of the key PTPs
activated by Leishmania (5, 12–14, 30). However, very little
work has been done concerning the ability of amastigotes to
activate host PTPs and SHP-1 in particular. The key role that
SHP-1 plays in amastigote infection can be deduced from in
vivo studies where amastigotes are exclusively found and where
the absence of SHP-1 was associated with increased resistance
to Leishmania infection (14). Additionally, it has been previ-
ously reported that Leishmania donovani amastigotes are able
to activate host SHP-1, yet the effect was claimed to be ob-
servable after 17 h of infection (29). In this work, we confirm
previous observations regarding the ability of promastigotes to
activate host PTPs (e.g., SHP-1). Importantly, we demonstrate
that amastigotes can rapidly activate host PTP activity (as early
as 0.5 h postinfection) (Fig. 2A) and that SHP-1 is a key
phosphatase rapidly activated by amastigote infection (Fig. 2B
and Fig. 3A, B, and C). This suggests that SHP-1 is a critical
phosphatase utilized by both forms of the parasite to inactivate
key M signaling pathways.
Interestingly, PTP-1B was activated by promastigote but not
amastigote infection (Fig. 2B and Fig. 3A, B, and C). This
phosphatase has been reported to bind to and negatively reg-
ulate JAK2 (28), while knockdown and overexpression studies
FIG. 7. Nuclear translocation of TFs in response to IFN- in Ms infected with WT or lmcpb/ L. mexicana promastigotes (P) and
amastigotes (A). B10R Ms were left uninfected, stimulated with IFN- (100 U/ml) for 6 h (), and infected (overnight [O/N]) with WT or
lmcpb/ promastigotes and amastigotes of L. mexicana in a 5:1 parasite-to-cell ratio, or they were infected (O/N) and then stimulated with IFN-
(100 U/ml) for 6 h. (A to C) Nuclear proteins were extracted and subjected to EMSA to evaluate the DNA-binding activity of NF-B (A), STAT-1
(B), and AP-1 (C). S, specific competition (100-fold excess of specific nonradioactive oligonucleotide); NS, nonspecific competition (100-fold excess
of nonspecific, nonradioactive Sp-1 oligonucleotide).
FIG. 8. Inability of lmcpb/ parasites to inhibit IFN--mediated
MNO production. NO assay of B10R Ms left untreated () (bar 1),
stimulated with IFN- (100 U/ml) for 24 h () (bar 2), infected with
WT (bars 3 and 4) or lmcpb/ (bars 7 and 8) L. mexicana (O/N, 20:1
ratio) (), or infected (O/N, 20:1 ratio) and then stimulated with
IFN- (100 U/ml) for 24 h (bars 5 and 6 and 9 and 10). The values are
means plus standard errors of the means (SEMs) (error bars). Values
that were significantly different (P 
 0.05, ANOVA test) are indicated
by an asterisk. The results are representative of at least three inde-
pendent experiments.
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suggested its role in the regulation of MyD88-dependent
proinflammatory cytokines, such as tumor necrosis factor al-
pha (TNF-), and the inhibition of NF-B and STAT-1 acti-
vation in Toll-like receptor (TLR)-triggered Ms (43). Given
that SHP-1 has also been associated with the ability to nega-
tively regulate JAK2 (5), block LPS-mediated TNF production
(1), and control NF-B and AP-1 activity (4), this finding
suggests that PTP-1B activated by promastigotes might have an
additive effect to SHP-1 action to help establish the parasite in
host cells. Indeed, data from our laboratory demonstrated that
Leishmania promastigote gp63 activated PTP-1B in a cleavage-
dependent manner and that PTP-1B/ mice infected with L.
major promastigotes showed a significant delay in the onset
and progression of footpad inflammation as well as lower par-
asite burden (15). Therefore, the selective activation of
PTP-1B by promastigotes is plausible, given that they are less
adapted to the host environment compared to amastigotes that
might find SHP-1 action sufficient to ensure their safe entry to
new uninfected phagocytes, especially since they seem to affect
some signaling molecules more drastically upon initial contact
with Ms, such as the strong inhibition they cause to NF-B,
STAT-1, and AP-1 compared to promastigotes (Fig. 4). It is
worth mentioning, however, that the utilization of host PTPs
other than SHP-1 by amastigotes is a possibility that cannot be
disregarded and deserves further investigation.
Consistent with a previous finding from our group, we have
shown that promastigotes cause cleavage of NF-B’s p65 sub-
unit, generating a smaller p35 subunit (16). On the other hand,
amastigotes caused complete NF-B degradation (Fig. 4A) as
previously shown (7). Also, consistent with previous findings,
promastigotes were able to cause degradation of STAT-1
(11) and inhibition of AP-1 (12) in Ms, but whether LmCPb
degrades STAT-1 on its own or in conjunction with the pro-
teasome, as we previously described for L. donovani (11), re-
mains to be determined. Importantly, we were able to demon-
strate for the first time that amastigotes of L. mexicana can also
cause rapid STAT-1 and AP-1 inhibition (Fig. 4). Very inter-
estingly, all the alterations caused by promastigotes and amas-
tigotes to NF-B, STAT-1, and AP-1 did not take place when
Ms were infected with lmcpb/ parasites. LmCPb has been
previously reported to play a role in the degradation of IB
and NF-B (7), interleukin 2 receptor (IL-2R), and the immu-
noglobulin E receptor(IgER) (34). Our data confirm the role
of LmCPb in NF-B degradation (Fig. 5A) and demonstrate
for the first time that LmCPb leads to the inhibition of
STAT-1 and AP-1 nuclear translocation and DNA-binding
activity, possibly by causing their degradation (Fig. 5B and C)
or by interfering with key phosphorylation steps (25, 44) re-
quired for their translocation to the nucleus. The protection of
these transcription factors seen when Ms were infected with
lmcpb/ parasites is reflected by the ability of these transcrip-
tion factors to translocate to the nucleus and bind their target
sequences in response to IFN- stimulation (Fig. 7), which
correlated with the ability of Ms to produce NO when stim-
ulated with IFN- following infection with lmcpb/ parasites
(Fig. 8). Importantly, the protection observed with lmcpb/
parasites cannot be due to their lower ability to enter Ms,
since staining experiments that we performed showed that WT
and lmcpb/ parasites could infect Ms at similar rates
(around 35% of total Ms become infected in a 1-h period
[data not shown]), nor can it be due to their attenuation while
they were multiply passaged in the knocking-out process, as
signaling alterations could again be seen when the Ms were
infected with lmcpb-rescued parasites (Fig. 6). Collectively, the
LmCPb-related findings presented here could help partially
explain the previously observed low infectivity of cpb mutants
(27), as well as further confirm the role of this cysteine pro-
teinase as a Leishmania virulence factor.
In conclusion, our comparison of promastigotes and amas-
tigotes of L. mexicana in terms of their ability to alter M
signaling yielded several interesting similarities as well as dif-
ferences. While both forms were able to activate total PTP
activity and to rapidly activate SHP-1, PTP-1B was activated
only by promastigotes. Additionally, while both forms caused
full inhibition of STAT-1 and AP-1, NF-B seemed to be
altered differently. Promastigotes cleaved NF-B’s p65 subunit
to p35 while amastigotes caused complete p65 inhibition with
no significant production of the smaller subunit. Importantly,
this study also revealed new roles for LmCPb as a virulence
factor by demonstrating its ability to interfere with STAT-1
and AP-1 transcriptional activity, therefore contributing to the
parasite’s ability to block IFN--induced NO production in
Ms, securing its survival and propagation within its mamma-
lian host.
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